Login to Your Account

Other news to note

Monday, February 24, 2014
Endo Pharmaceuticals Inc., of Malvern, Pa., reached a resolution of criminal and civil claims with the federal and participating state authorities and the District of Columbia regarding a previously disclosed investigation concerning past U.S. sales, marketing and promotional practices related to its product Lidoderm (lidocaine patch 5 percent).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription